RA CAPITAL MANAGEMENT, L.P. Q1 2017 Filing
Filed May 15, 2017
Portfolio Value
$815.3B
Holdings
24
Report Date
Q1 2017
Filing Type
13F-HR
All Holdings (24 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | WVEWAVE LIFE SCIENCES LTD | 7,088,651 | $194.9B | 23.91% | |
| 2 | ASNDASCENDIS PHARMA A S | 5,409,990 | $151.5B | 18.58% | |
| 3 | —AVEXIS INC | 1,625,211 | $123.6B | 15.16% | |
| 4 | —ACHILLION PHARMACEUTICALS INC | 13,633,220 | $57.4B | 7.04% | |
| 5 | —AQUINOX PHARMACEUTICALS INC | 2,184,047 | $36.2B | 4.44% | |
| 6 | BCRXBIOCRYST PHARMACEUTICALS | 3,489,795 | $29.3B | 3.60% | |
| 7 | —RA PHARMACEUTICALS INC | 1,351,808 | $28.8B | 3.53% | |
| 8 | —MYOVANT SCIENCES LTD | 2,348,422 | $27.6B | 3.38% | |
| 9 | —ZOGENIX INC | 2,451,237 | $26.6B | 3.26% | |
| 10 | ESPRESPERION THERAPEUTICS INC | 704,701 | $24.9B | 3.05% | |
| 11 | —LOXO ONCOLOGY INC | 298,935 | $12.6B | 1.54% | |
| 12 | ARDXARDELYX INC | 828,283 | $10.5B | 1.29% | |
| 13 | —ACORDA THERAPEUTICS INC | 489,828 | $10.3B | 1.26% | |
| 14 | —AUDENTES THERAPEUTICS INC | 532,426 | $9.1B | 1.11% | |
| 15 | —FOAMIX PHARMACEUTICALS LTD | 1,820,138 | $9.0B | 1.11% | |
| 16 | —IGNYTA INC | 1,025,291 | $8.8B | 1.08% | |
| 17 | ONCBEIGENE LTD | 240,000 | $8.8B | 1.08% | |
| 18 | —CALITHERA BIOSCIENCES INC | 725,000 | $8.4B | 1.03% | |
| 19 | —DICERNA PHARMACEUTICALS INC | 2,428,571 | $8.3B | 1.01% | |
| 20 | TGTXTG THERAPEUTICS INC | 700,000 | $8.2B | 1.00% | |
| 21 | PTGXPROTAGONIST THERAPEUTICS INC | 636,248 | $8.2B | 1.00% | |
| 22 | KALVKALVISTA PHARMACEUTICALS INC | 591,070 | $4.6B | 0.57% | |
| 23 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 354,200 | $4.1B | 0.50% | |
| 24 | —MEDICINES CO | 79,899 | $3.9B | 0.48% |